跳至主要内容
临床试验/ACTRN12617001025325
ACTRN12617001025325已完成4 期

Efficacy and safety of Artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Zhob of Balochistan province and Khyber Agency of FATA, Pakistan

Ministry of National Health Services Regulations and Coordination0 个研究点目标入组 176 人开始时间: 2017年7月14日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Months 至 60 Years(—)
性别
All

入选标准

  • 1.Age between 6 months and above with the exception of 12-17 years old female minors and unmarried females above 18 years and above;
  • 2.Mono-infection with P. falciparum detected by microscopy;
  • 3.Parasitaemia of 500 – 200000 per microL asexual forms;
  • 4.Presence of axillary or tympanic temperature greater or equal to 37.5 degrees centigrade or history of fever during the past 24 h;
  • 5.Ability to swallow oral medication;
  • 6.Ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule;
  • 7.Informed consent from the patient or from a parent or guardian in the case of children aged less than 18 years;
  • 8.Informed assent from any minor participant aged from 12 to 17 years; and
  • 9.Consent for pregnancy testing from married female aged 18 years and above.

排除标准

  • 1.Presence of general danger signs in children aged under 12 years or signs of severe falciparum malaria according to the definitions of WHO;
  • 2.Weight under 5 kg;
  • 3.Mixed or mono-infection with another Plasmodium species detected by microscopy;
  • 4.Presence of severe malnutrition defined as a child aged 6-60 months who has a mid-upper arm circumference below 115 mm);
  • 5.Presence of febrile conditions due to diseases other than malaria (e.g. measles, acute lower respiratory tract infection, severe diarrhea with dehydration) or other known underlying chronic or severe diseases (e.g. cardiac, renal and hepatic diseases, HIV/AIDS);
  • 6.Regular medication, which may interfere with antimalarial pharmacokinetics;
  • 7.History of hypersensitivity reactions or contraindications to any of the medicine(s) being tested or used as alternative treatment(s);
  • 8.A positive pregnancy test or breastfeeding of married women aged 18 years and above; and
  • 9.Unable to or unwilling to take pregnancy test or to use contraception for women of child-bearing age and who are sexually active.

研究者

发起方
Ministry of National Health Services Regulations and Coordination

相似试验